Abstract
The NOSTRADAMUS study (ISRCTN07836779) was prematurely terminated due to low inclusion rates. There were several causes for this low inclusion: delay of approval by medical ethics committees, competition with industry-initiated intervention studies with a higher financial compensation, and the lack of study staff and allowance of expenses. We advise restraint with respect to testing for thrombophilia in patients with a first deep vein thrombosis or pulmonary embolism, as the benefit of this procedure has yet to be demonstrated
Original language | Dutch |
---|---|
Pages (from-to) | 2093-2094 |
Journal | Nederlands Tijdschrift voor Geneeskunde |
Volume | 152 |
Issue number | 38 |
Publication status | Published - 2008 |